Suppression of nonhomologous end joining repair by overexpression of HMGA2
- PMID: 19549901
- PMCID: PMC2737594
- DOI: 10.1158/0008-5472.CAN-08-4833
Suppression of nonhomologous end joining repair by overexpression of HMGA2
Abstract
Understanding the molecular details associated with aberrant high mobility group A2 (HMGA2) gene expression is key to establishing the mechanism(s) underlying its oncogenic potential and effect on the development of therapeutic strategies. Here, we report the involvement of HMGA2 in impairing DNA-dependent protein kinase (DNA-PK) during the nonhomologous end joining (NHEJ) process. We showed that HMGA2-expressing cells displayed deficiency in overall and precise DNA end-joining repair and accumulated more endogenous DNA damage. Proper and timely activation of DNA-PK, consisting of Ku70, Ku80, and DNA-PKcs subunits, is essential for the repair of DNA double strand breaks (DSB) generated endogenously or by exposure to genotoxins. In cells overexpressing HMGA2, accumulation of histone 2A variant X phosphorylation at Ser-139 (gamma-H2AX) was associated with hyperphosphorylation of DNA-PKcs at Thr-2609 and Ser-2056 before and after the induction of DSBs. Also, the steady-state complex of Ku and DNA ends was altered by HMGA2. Microirradiation and real-time imaging in living cells revealed that HMGA2 delayed the release of DNA-PKcs from DSB sites, similar to observations found in DNA-PKcs mutants. Moreover, HMGA2 alone was sufficient to induce chromosomal aberrations, a hallmark of deficiency in NHEJ-mediated DNA repair. In summary, a novel role for HMGA2 to interfere with NHEJ processes was uncovered, implicating HMGA2 in the promotion of genome instability and tumorigenesis.
Figures




Comment in
-
Comment re: HMGA2 is a negative regulator of DNA-PK pathway.Cancer Res. 2010 Feb 15;70(4):1742; author reply 1742. doi: 10.1158/0008-5472.CAN-09-3081. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145117 No abstract available.
Similar articles
-
The N-terminal region of the DNA-dependent protein kinase catalytic subunit is required for its DNA double-stranded break-mediated activation.J Biol Chem. 2013 Mar 8;288(10):7037-46. doi: 10.1074/jbc.M112.434498. Epub 2013 Jan 15. J Biol Chem. 2013. PMID: 23322783 Free PMC article.
-
Biochemical evidence for Ku-independent backup pathways of NHEJ.Nucleic Acids Res. 2003 Sep 15;31(18):5377-88. doi: 10.1093/nar/gkg728. Nucleic Acids Res. 2003. PMID: 12954774 Free PMC article.
-
The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV.Mutagenesis. 2007 May;22(3):217-33. doi: 10.1093/mutage/gem007. Epub 2007 Mar 7. Mutagenesis. 2007. PMID: 17347130
-
Mechanisms of DNA double strand break repair and chromosome aberration formation.Cytogenet Genome Res. 2004;104(1-4):14-20. doi: 10.1159/000077461. Cytogenet Genome Res. 2004. PMID: 15162010 Review.
-
Coordination of DNA-PK activation and nuclease processing of DNA termini in NHEJ.Antioxid Redox Signal. 2011 Jun 15;14(12):2531-43. doi: 10.1089/ars.2010.3368. Epub 2010 Dec 2. Antioxid Redox Signal. 2011. PMID: 20698792 Free PMC article. Review.
Cited by
-
HMGA2 as a Critical Regulator in Cancer Development.Genes (Basel). 2021 Feb 13;12(2):269. doi: 10.3390/genes12020269. Genes (Basel). 2021. PMID: 33668453 Free PMC article. Review.
-
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.J Clin Oncol. 2010 May 10;28(14):2467-74. doi: 10.1200/JCO.2009.26.6213. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368557 Free PMC article.
-
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.Nat Commun. 2014 Jul 31;5:4527. doi: 10.1038/ncomms5527. Nat Commun. 2014. PMID: 25078033 Free PMC article.
-
HMGA2 and high-grade serous ovarian carcinoma.J Mol Med (Berl). 2013 Oct;91(10):1155-65. doi: 10.1007/s00109-013-1055-8. Epub 2013 May 19. J Mol Med (Berl). 2013. PMID: 23686260 Review.
-
Shifting perspectives from "oncogenic" to oncofetal proteins; how these factors drive placental development.Reprod Biol Endocrinol. 2018 Oct 19;16(1):101. doi: 10.1186/s12958-018-0421-3. Reprod Biol Endocrinol. 2018. PMID: 30340501 Free PMC article. Review.
References
-
- Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions (Review) Int J Oncol. 2008;32:289–305. - PubMed
-
- Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995;376:771–4. - PubMed
-
- Monzen K, Ito Y, Naito AT, et al. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat Cell Biol. 2008;10:567–74. - PubMed
-
- Fedele M, Visone R, De Martino I, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell. 2006;9:459–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials